Gloria E Borgstahl

US Patent:

20050074092, Apr 7, 2005

Filed:

Oct 7, 2003

Appl. No.:

10/681874

Inventors:

Gloria Borgstahl - Omaha NE, US
Jeff Lovelace - Omaha NE, US
Edward Snell - Ardmore AL, US
Henry Bellamy - Baton Rouge LA, US

International Classification:

H05G001/64

US Classification:

378098800

Abstract:

The present invention provides a digital topography imaging system that may be employed to determine crystalline structure of a sample and methods for using said system.

US Patent:

20060259245, Nov 16, 2006

Filed:

Apr 5, 2006

Appl. No.:

11/278738

Inventors:

Gloria Borgstahl - Omaha NE, US
Jeff Lovelace - Omaha NE, US
Edward Snell - Lancaster NY, US
Henry Bellamy - Baton Rouge LA, US

International Classification:

G06F 19/00
G01T 1/00

US Classification:

702019000, 378002000

Abstract:

The present invention provides a digital topography imaging system for determining the crystalline structure of a biological macromolecule, wherein the system employs a charge coupled device (CCD) camera with antiblooming circuitry to directly convert x-ray signals to electrical signals without the use of phosphor and measures reflection profiles from the x-ray emitting source after x-rays are passed through a sample. Methods for using said system are also provided.

US Patent:

20220339279, Oct 27, 2022

Filed:

Apr 15, 2022

Appl. No.:

17/721709

Inventors:

- Lincoln NE, US
Gloria Borgstahl - Omaha NE, US
Siddappa Byrareddy - Omaha NE, US
Chittibabu Guda - Omaha NE, US
Mara Jana Broadhurst - Omaha NE, US
Andrew Schnaubelt - Papillion NE, US

International Classification:

A61K 39/215
C07K 14/165
A61P 31/14
G01N 33/569

Abstract:

Disclosed are recombinant proteins, compositions, vectors, kits, data analyses, and methods for inducing an immune response against, or detecting exposure to, SARS-CoV-2. In particular, the compositions, vectors, kits, data analyses and methods may be utilized to immunize subjects against disease associated with SARS-CoV-2 infection or to protect subjects from SARS-CoV-2 infection. In some embodiments, the recombinant proteins are useful in the production of antibodies against SARS-CoV-2, and for the detection of exposure to SARS-CoV-2.